GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Simulations Plus Inc (NAS:SLP) » Definitions » Net Cash per Share
中文

Simulations Plus (Simulations Plus) Net Cash per Share : $4.58 (As of Feb. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Simulations Plus Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Simulations Plus's Net Cash per Share for the quarter that ended in Feb. 2024 was $4.58.

The historical rank and industry rank for Simulations Plus's Net Cash per Share or its related term are showing as below:

SLP' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 6.8   Med: 11.46   Max: 1025.5
Current: 10.19

During the past 13 years, the highest Price-to-Net-Cash Ratio of Simulations Plus was 1025.50. The lowest was 6.80. And the median was 11.46.

SLP's Price-to-Net-Cash is ranked worse than
57.04% of 135 companies
in the Healthcare Providers & Services industry
Industry Median: 8 vs SLP: 10.19

Simulations Plus Net Cash per Share Historical Data

The historical data trend for Simulations Plus's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Simulations Plus Net Cash per Share Chart

Simulations Plus Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Net Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.22 5.20 5.43 5.83 4.99

Simulations Plus Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.36 5.65 4.99 5.03 4.58

Competitive Comparison of Simulations Plus's Net Cash per Share

For the Health Information Services subindustry, Simulations Plus's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Simulations Plus's Price-to-Net-Cash Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Simulations Plus's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Simulations Plus's Price-to-Net-Cash falls into.



Simulations Plus Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Simulations Plus's Net Cash per Share for the fiscal year that ended in Aug. 2023 is calculated as

Net Cash per Share (A: Aug. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(115.463-16.072-0)/19.938
=4.99

Simulations Plus's Net Cash per Share for the quarter that ended in Feb. 2024 is calculated as

Net Cash per Share (Q: Feb. 2024 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(108.504-16.935-0)/19.9837
=4.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Simulations Plus  (NAS:SLP) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Simulations Plus Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Simulations Plus's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Simulations Plus (Simulations Plus) Business Description

Traded in Other Exchanges
N/A
Address
42505 Tenth Street West, Lancaster, CA, USA, 93534-7059
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. It generates maximum revenue from the software segment.
Executives
John Kenneth Paglia director 746 GRABLE PLACE, NEWBURY PARK CA 91320
Walter S Woltosz director, 10 percent owner, officer: Chairman and CEO 42505 10TH ST. WEST, LANCASTER CA 93534
Dibella John Anthony Ii officer: Division President 42505 10TH STREET WEST, LANCASTER CA 93534
Lisa Lavange director 42505 10TH ST., WEST, LANCASTER CA 93534
Steven Chang officer: President, Immunetrics 42505 10TH STREET WEST, LANCASTER CA 15203
Shawn Oconnor officer: Chief Executive Officer 42505 10TH STREET WEST, LANCASTER CA 93534-7059
Jill Fiedler-kelly officer: President, Cognigen Division 42505 10TH STREET WEST, LANCASTER CA 93534
Brett Howell officer: President, DILIsym Division 42505 10TH STREET WEST, LANCASTER CA 93534
William W Frederick officer: CFO C/O SIMULATIONS PLUS, INC., 42505 10TH STREET WEST, LANCASTER CA 93534
Daniel L Weiner director 800 WEST EL CAMINO REAL, SUITE 200, MOUNTAIN VIEW CA 94040
Sharlene Evans director 42505 10TH STREET WEST, LANCASTER CA 93534
Nguyen Nguyen officer: VP of Human Resources 42505 TENTH STREET WEST, LANCASTER CA 93534
David L. Ralph director 42505 10TH STREET WEST, LANCASTER CA 93534
John Robert Kneisel officer: CFO 42505 10TH STREET WEST, LANCASTER CA 93534
Grasela Thaddeus Henry Jr director, officer: President 1780 WEHRLE DRIVE SUITE 110, BUFFALO NY 14221